SEC Comment Letter 0000000000-24-001057 to BIMI Holdings Inc. (BIMI) (CIK 0001213660)
BIMI Holdings Inc. (BIMI) (CIK 0001213660)
Date: Jan. 26, 2024 · CIK: 0001213660 · Accession: 0000000000-24-001057
AI Filing Summary & Sentiment
File numbers found in text: 001-34890
Letter
United States securities and exchange commission logo January 26, 2024 Tiewei Song Chief Executive Officer BIMI International Medical Inc. 9th Floor, Building 2 Chongqing Corporation Avenue Yuzhong District, Chongqing, P. R. China, 400010 Re:BIMI International Medical Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed May 4, 2023 Correspondence Filed April 24, 2023 File No. 001-34890 Dear Tiewei Song: We issued comments to you on the above captioned filings on July 17, 2023. As of the date of this letter, these comments remain outstanding and unresolved. We expect you to provide a complete, substantive response to these comments by February 9, 2024. If you do not respond, we will, consistent with our obligations under the federal securities laws, decide how we will seek to resolve material outstanding comments and complete our review of your filings and your disclosure. Among other things, we may decide to release publicly, through the agency's EDGAR system, all correspondence, including this letter, relating to the review of your filings, consistent with the staff's decision to publicly release comment and response letters relating to disclosure filings it has reviewed. Please contact Nasreen Mohammed at 202-551-3773 or Adam Phippen at 202-551-3336 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: Pang Zhang-Whitaker
Show Raw Text
United States securities and exchange commission logo
January 26, 2024
Tiewei Song
Chief Executive Officer
BIMI International Medical Inc.
9th Floor, Building 2
Chongqing Corporation Avenue
Yuzhong District, Chongqing,
P. R. China, 400010
Re:BIMI International Medical Inc.
Form 10-K for the Fiscal Year Ended December 31, 2022
Filed May 4, 2023
Correspondence Filed April 24, 2023
File No. 001-34890
Dear Tiewei Song:
We issued comments to you on the above captioned filings on July 17, 2023. As of the
date of this letter, these comments remain outstanding and unresolved. We expect you to provide
a complete, substantive response to these comments by February 9, 2024.
If you do not respond, we will, consistent with our obligations under the federal securities
laws, decide how we will seek to resolve material outstanding comments and complete our
review of your filings and your disclosure. Among other things, we may decide to release
publicly, through the agency's EDGAR system, all correspondence, including this letter, relating
to the review of your filings, consistent with the staff's decision to publicly release comment and
response letters relating to disclosure filings it has reviewed.
Please contact Nasreen Mohammed at 202-551-3773 or Adam Phippen at 202-551-3336
with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc: Pang Zhang-Whitaker